BSE filing, NSE: FISCHER. Summary written from the filing by ALFA Finder's alert engine.
Fischer Medical Ventures Ltd: key numbers
- Share price
- ₹24.79
- Market cap
- ₹1,717 Cr
- Revenue (annual)
- ₹308.6 Cr
- Net profit (annual)
- ₹31.02 Cr
- P/E (TTM)
- 57.6×Sector 34.1×
- Promoter holding
- 63.08%+0.93% QoQ
- FII holding
- 6.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fischer Medical Ventures Ltd
All →Fischer Medical Ventures Management Change
Fischer Medical Ventures appointed Mr. Chan Sing En as Independent Director of SG subsidiary FMV Global Innovations, effective 27 Oct 2026. No financial consideration involved.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Ltd has issued a Postal Ballot Notice seeking shareholder approval for creating security on subsidiary assets and promoter share pledges for proposed NCD issuance.
Fischer Medical Ventures Board Meeting Outcome
Fischer Medical Ventures' board approved a postal ballot notice for RPT consent and borrowing limits, and appointed a scrutinizer. No material transaction or financial figure was decided at this meeting.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Limited conducted its 33rd Annual General Meeting via video conferencing on September 29, 2026, with the requisite quorum present.
Fischer Medical Ventures Other Announcement
Fischer Medical Ventures' subsidiaries declared dividends totaling ₹26.95 Crore. This update provides financial information regarding subsidiary cash flows to the exchange.
- Value
- ₹26.95 Cr
Fischer Medical Ventures Annual Report
The company issued a corrigendum to its FY 2025-26 Annual Report. This update corrects financial highlights, auditor report details, and capital management tables.
Other other announcement announcements
All →Repono Other Announcement
Repono Ltd filed its half-yearly shareholding pattern as of September 30, 2026. Promoter and promoter group hold 72.47% of shares, a routine compliance disclosure.
Shanthala FMCG Products Other Announcement
Shanthala FMCG declared Regulation 23 related party transaction disclosures do not apply for the year ended 31 March 2026. The company is SME-listed and below the threshold.
Mitsu Chem Plast Other Announcement
Mitsu Chem Plast reported that its statutory auditor, Gokhale & Sathe, converted into Gokhale & Sathe LLP effective 27 August 2026. The engagement and tenure remain unchanged.
Sonu Infratech Other Announcement
Sonu Infratech reported full utilisation of Rs.551.24 lakh raised from warrant conversion, with no deviation. The Audit Committee reviewed the statement and auditors issued no comments.
DOMS Industries Other Announcement
DOMS Industries filed its quarterly shareholding pattern for the period ended 30 September 2026. It is a periodic statement with no transaction or reclassification.
Alphalogic Techsys Other Announcement
Alphalogic Techsys filed its Reg 32 utilisation statement for the quarter ended September 2026. Rs 1.35 Crore raised via warrant allotment was fully used with no deviation.
- Value
- ₹1.35 Cr